24-Apr-2026
No headlines found.
Cohen & Steers Reports Results for First Quarter 2026
PRNewswire (Thu, 16-Apr 4:18 PM ET)
Cohen & Steers Announces U.S. Wealth Leadership Appointments
PRNewswire (Tue, 14-Apr 9:01 AM ET)
Cohen & Steers Announces Preliminary Assets Under Management and Net Flows for March 2026
PRNewswire (Thu, 9-Apr 4:20 PM ET)
Cohen & Steers, Inc. to Release First Quarter 2026 Results on April 16, 2026
PRNewswire (Wed, 8-Apr 4:20 PM ET)
PRNewswire (Mon, 30-Mar 4:00 PM ET)
PRNewswire (Mon, 30-Mar 4:00 PM ET)
PRNewswire (Mon, 30-Mar 4:00 PM ET)
PRNewswire (Mon, 30-Mar 4:00 PM ET)
PRNewswire (Mon, 30-Mar 4:00 PM ET)
Cohen & Steers Closed-End Funds Declare Distributions for April, May and June 2026
PRNewswire (Tue, 24-Mar 5:07 PM ET)
Cohen & Steers is a niche asset manager concentrating on real estate securities. The firm invests mainly in the equity shares of real estate investment trusts, with holdings in domestic and international real estate securities accounting for around two-thirds of its $98.4 billion in managed assets at the end of February. Cohen & Steers also manages portfolios dedicated to preferred securities, utilities stocks, and other high-yield offerings. The firm's distribution is balanced among its closed-end funds, open-end funds, and institutional accounts. During the past four calendar quarters, the company garnered 39% (25%) of its managed assets (base management fees) from institutional clients, 48% (55%) from open-end funds, and 13% (20%) from closed-end funds.
Cohen & Steers trades on the NYSE stock market under the symbol CNS.
As of April 24, 2026, CNS stock price climbed to $67.71 with 175,359 million shares trading.
CNS has a beta of 1.03, meaning it tends to be more sensitive to market movements. CNS has a correlation of 0.31 to the broad based SPY ETF.
CNS has a market cap of $3.48 billion. This is considered a Mid Cap stock.
Last quarter Cohen & Steers reported $146 million in Revenue and $.79 earnings per share. This beat revenue expectation by $2 million and missed earnings estimates by -$.03.
In the last 3 years, CNS traded as high as $110.67 and as low as $50.05.
The top ETF exchange traded funds that CNS belongs to (by Net Assets): IJR, VTI, IWM, SCHD, VB.
CNS has underperformed the market in the last year with a return of -5.4%, while the SPY ETF gained +34.7%. In the last 3 month period, CNS fell short of the market, returning +3.7%, while SPY returned +3.8%. However, in the most recent 2 weeks CNS has outperformed the stock market by returning +5.7%, while SPY returned +5.0%.
CNS support price is $65.86 and resistance is $68.62 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CNS shares will trade within this expected range on the day.